Pharming (PHAR) Share-based Compensation (2020 - 2025)

Pharming's Share-based Compensation history runs 6 years deep, the most recent figure standing at $4.5 million for Q4 2025.

• Quarterly Share-based Compensation rose 70.64% year-over-year to $4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.4 million (up 23.47% YoY) and the FY2025 annual result came in at $13.8 million, up 22.39% from the prior year.
• Share-based Compensation was $4.5 million for Q4 2025 at Pharming, up from $2.6 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.5 million in Q4 2025 and bottomed at -$3.7 million in Q3 2021.
• A 5-year average of $1.8 million and a median of $2.0 million in 2023 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 27886.73% in 2021, while the deepest fall reached 548.57% in 2021.
• Pharming's Share-based Compensation stood at $1.9 million in 2021, then plunged by 43.95% to $1.1 million in 2022, then jumped by 209.91% to $3.3 million in 2023, then dropped by 20.3% to $2.6 million in 2024, then surged by 70.64% to $4.5 million in 2025.
• Business Quant data shows PHAR's Share-based Compensation at $4.5 million in Q4 2025, $2.6 million in Q4 2024, and $2.9 million in Q3 2024.